Tag Archives: multiple myeloma

US FDA Approves Tecvayli® (Teclistamab-cqyv) for Relapsed/Refractory Multiple Myeloma (RRMM)

On October 25, 2022, the US FDA granted accelerated approval to Tecvayli® (teclistamab-cqyv, Janssen Biotech, Inc.) for adult patients with […]

October 28, 2022

Food and Drug Administration Approves CAR T-Cell Therapy for Multiple Myeloma

The first cell-based gene therapy for multiple myeloma has been approved by the US Food and Drug Administration. Approval of […]

April 15, 2021

Teclistamab Demonstrates Continued Promise in Relapsed/Refractory MM

According to outcomes from an ongoing phase 1 study, a bispecific BCMA (B-cell maturation antigen) x CD3 antibody named Teclistamab […]

March 16, 2021

Multiple Myeloma: Treatment and Medications

Being the second most common type of blood cancer, 5-6% of the world population is diagnosed with Multiple Myeloma every […]

December 8, 2020